Investigation of the Effect of Faradarmani Consciousness Field on NF-κB and proinflammatory factors Gene Expression Using Blood Samples of Patients with Covid-19

Authors Mohammad Ali Taheri, Laleh Amani, Behzad Azimi, Ali Zaman Vaziri, Hossein Keyvani
Publication date Apr 16, 2022
Journal Journal of Cosmointel
Volume cover_issue_v1n1_en_US-scaled Vol. 1 No. 1
Pages 37 to 42
Publisher Cosmointel Inc.


The Coronavirus disease 2019 (COVID-19) pandemic has become a worldwide challenge. Severe respiratory distress syndrome (ARDS) caused by coronavirus has often been associated with a cytokine storm. The Faradarmani Consciousness Field, as one of many Taheri Consciousness Fields (TCFs) introduced by Mohammad Ali Taheri, is a novel field that is neither matter nor energy. Therefore, it is non-quantifiable and cannot be directly observed or measured. However, it is possible to demonstrate and measure the effects of these TCFs through standard scientific experiments. The current study aimed to investigate the effect of Faradarmani CF on inflammatory factors in blood samples of patients with COVID-19. Blood samples were taken from 53 COVID-19 patients to examine the mRNA expression of NF-κBTNF-α, IL- 1β, and IL-6 genes in Faradarmani CF and control groups of samples. The results indicated that under the influence of Faradarmani CF, the expression of NF-κB and IL-1β genes was significantly decreased (p < 0.05), and the TNF-α gene expression was significantly increased (p < 0.05), but the expression of IL-6 did not show any significant change (p>0.05). We conclude that immunomodulation at the level of NF-κB and IL-1β by Faradarmani CF may inhibit the cytokine storm in COVID-19 patients. However, further studies are required to identify all effects of this T-Consciousness Field.

Keywords: COVID-19, Faradarmani, Taheri Consciousness Fields, T-Consciousness, Proinflammatory factors

Citation: Taheri, . M. A. ., Amani, L., Azimi, B., Vaziri, A. Z., & Keyvani, H. (2022). Investigation of the Effect of Faradarmani Consciousness Field on NF-κB and Proinflammatory Factors Genes Expression Using Blood Samples of Patients with COVID-19. Journal of Cosmointel1(1), 37–42. Retrieved from